Apellis Pharmaceuticals (NASDAQ:APLS) Issues Quarterly Earnings Results, Misses Estimates By $0.14 EPS
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.14), Briefing.com reports. Apellis Pharmaceuticals had a negative return on equity of 138.32% and a negative net margin of 52.99%. The business had revenue […]
More Stories
Grizzly Discoveries (CVE:GZD) Sets New 1-Year Low – What’s Next?
Grizzly Discoveries Inc. (CVE:GZD – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Monday...
Trakm8 (LON:TRAK) Sets New 12-Month Low – What’s Next?
Trakm8 Holdings PLC (LON:TRAK – Get Free Report)’s stock price reached a new 52-week low on Monday . The company...
MGIC Investment (NYSE:MTG) Hits New 52-Week High – Still a Buy?
MGIC Investment Co. (NYSE:MTG – Get Free Report)’s share price reached a new 52-week high on Monday . The company...
ProShares Bitcoin ETF (NYSEARCA:BITO) Shares Down 4.5% – Should You Sell?
Shares of ProShares Bitcoin ETF (NYSEARCA:BITO – Get Free Report) dropped 4.5% on Monday . The stock traded as low...
Coursera (NYSE:COUR) Sees Strong Trading Volume – Here’s What Happened
Coursera, Inc. (NYSE:COUR – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 8,975,964 shares changed hands...
Zephyr Minerals (CVE:ZFR) Sets New 52-Week Low – What’s Next?
Zephyr Minerals Ltd. (CVE:ZFR – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock...